Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today ...

Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular"), a biopharmaceutical company committed to redefining the retina experience, announced the launch of ...

The Inducement Grant has a ten-year term and an exercise price per share of $9.97, which is equal to the closing price of Zenas’ common stock on the Grant Date. The Inducement Grant will vest over a ...

SAN JOSE, CA / ACCESS Newswire / June 27, 2025 / Peraso Inc. (NASDAQ:PRSO) ("Peraso" or the "Company"), a pioneer in mmWave ...

Supermicro's BigTwin® Multi-Node Server with 5th Gen Intel® Xeon® Scalable Processors is now certified by IntelServer system ...

Extends Lending Relationship and Expands Credit Facility Borrowing Capacity with Texas Capital Bank CHELMSFORD, MASSACHUSETTS / ACCESS Newswire / June 30, 2025 / Harte Hanks, Inc. (NASDAQ:HHS), a ...

Welcome to today’s conference call to discuss Rocky Mountain Chocolate Factory’s financial results for the fiscal fourth quarter and full year 2025. [Operator Instructions]. As a reminder, this ...

New name aligns with mission to deliver precision biomarker-based testing for both transplant and oncology care iMDx sponsoring GraftAssureIQ™ research-use-only kits at transplant labs globally ...

Nasdaq handily beat the New York Stock Exchange in stock market listings during the first half of 2025, buoyed by blockbuster ...

The Nasdaq-100 index’s unusually strong rally has left investors questioning whether U.S. large-cap tech stocks are ...

Halfway into 2025, the capital raised in U.S.-listed IPOs has already reached 73% of 2024's full-year volume, according to ...

TherapeuticsMD Inc. closed 53.69% short of its 52-week high of $2.44, which the company reached on January 3rd.